Daily non-political popular news in brief.

UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

In a paper to be published this month in the journal Small, researchers at UCLA from the California NanoSystems Institute and the Jonsson Comprehensive Cancer Center report a novel approach using silica-based nanoparticles for the delivery of camptothecin and other water-insoluble drugs into human cancer cells.

Read more »

Keywords: ucla, researchers, develop, nanomaterials, deliver, anti-cancer, drugs, cells, researcher, nanomaterial, anti, cancer, drug, cell

« Previous | Next »

Similar news on "UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells":

1. UCLA researchers develop new nanomaterials to deliver anticancer drugs to cells
   06-06-2007 · EurekAlert!
   In a paper to be published this month in the journal Small, researchers at UCLA from the California NanoSystems Institute and the Jonsson Comprehensive Cancer Center report a novel approach using silica-based nanoparticles for the delivery of camptothecin and other water-insoluble drugs into human cancer cells.
   Similar news · Read more »
   
2. Taxol bristle ball: a wrench in the works for cancer
   09-12-2007 · EurekAlert!
   Rice University chemists have discovered a way to load dozens of molecules of the anti-cancer drug Taxol onto tiny gold spheres. The result is a ball many times smaller than a living cell that literally bristles with the drug. Researchers hope to use the Taxol bristle ball to deliver large quantities of Taxol directly to cancer cells. The research will appear in the Sept. 19 issue of the Journal of the American Chemical Society.
   Similar news · Read more »
   
3. Nanoengineers mine tiny diamonds for drug delivery
   10-12-2007 · EurekAlert!
   Northwestern University researchers have shown that nanodiamonds are very effective at delivering chemotherapy drugs to cells without the negative effects associated with current drug delivery agents. Their study is the first to demonstrate the use of nanodiamonds, a new class of nanomaterials, in biomedicine. In addition to delivering cancer drugs, the model could be used for other applications, such as fighting tuberculosis or viral infections, say the researchers.
   Similar news · Read more »
   
4. Researchers develop simple method to create natural drug products
   09-04-2007 · EurekAlert!
   Until now, only the intricate machinery inside cells could take a mix of enzyme ingredients, blend them together and deliver a natural product with an elaborate chemical structure such as penicillin. Researchers at UC San Diego's Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences and the University of Arizona have for the first time demonstrated the ability to mimic this process outside of a cell.
   Similar news · Read more »
   
5. MIT model could predict cells' response to drugs
   07-30-2007 · EurekAlert!
   MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
   Similar news · Read more »
   
6. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
7. Study Reveals Mechanism For Cancer-drug Resistance
   10-11-2006 · ScienceDaily
   Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs.
   Similar news · Read more »
   
8. Impaired Gene Helps Nonsmall-cell Lung Cancer Resist Drug
   10-02-2006 · ScienceDaily
   Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease, researchers at the University of Texas M. D. Anderson Cancer Center and the University of Texas Southwestern Medical Center at Dallas report in the cover article of the Oct. 1 edition of Cancer Research.
   Similar news · Read more »
   
9. Ireland Cancer Center researchers advance lung cancer treatment
   04-23-2007 · EurekAlert!
   Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
   Similar news · Read more »
   
10. Bone marrow microenvironment can contribute to blood cell disorder
    06-14-2007 · EurekAlert!
    Disorders of blood cells may begin in the biological environment where the cells develop, not just with the cells themselves, according to a study from researchers at the Massachusetts General Hospital and the Peter MacCallum Cancer Center in Melbourne, Australia.
    Similar news · Read more »